| Serial Number | 90593460 |
| Word Mark | STELLAR TRIALBRIDGE |
| Filing Date | Monday, March 22, 2021 |
| Status | 700 - REGISTERED |
| Status Date | Tuesday, June 13, 2023 |
| Registration Number | 7081324 |
| Registration Date | Tuesday, June 13, 2023 |
| Mark Drawing | 3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | Tuesday, April 19, 2022 |
| Description of Mark | The mark consists of the wording "Stellar TrialBridge" in stylized font with a horizontal line between the words, and a stylized laboratory flask featuring two double helix designs and seven shaded hexagons shapes, two of which are connected. |
| Goods and Services | Software as a service (SAAS) services featuring software for use in managing data and information in the field of medical clinical trials and research, for use in clinical trial monitoring and events capture in the nature of gathering and organizing information and data generated in medical clinical trials and research, and for use in clinical data capture, management and reporting in the nature of the results of medical clinical trials and research; providing online non-downloadable software for use in managing data and information in the field of medical clinical trials and research, namely, clinical trial design and protocol development, clinical trial planning and management, clinical trial user and learning management, clinical trial operational reporting and analytics, clinical trial randomization and trial supply management, clinical trial monitoring and events capture and clinical data capture, management and reporting; Application service provider (ASP) featuring software using artificial intelligence for use in managing data and information in the field of medical clinical trials and research, for use in clinical trial monitoring and events capture in the nature of gathering and organizing information and data generated in medical clinical trials and research, and for use in clinical data capture, management and reporting in the nature of the results of medical clinical trials and research; Conducting clinical trials for others; Conducting early evaluations in the field of new pharmaceuticals; Conducting research and clinical trials for others relating to medical devices and pharmaceuticals in the field of ophthalmology; Consulting services in the fields of biotechnology, pharmaceutical research and development and genetic science; Consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, diagnostics, and pharmacogenetics; Development of pharmaceutical preparations and medicines; Laboratory research services relating to pharmaceuticals; Medical and scientific research in the field of pharmaceuticals and medical devices, namely, designing, organizing, conducting, monitoring, and managing clinical and non-clinical trials and studies on pharmaceuticals and medical devices for others; Medical and scientific research, namely, conducting clinical trials for others; Pharmaceutical drug development services; Pharmaceutical product evaluation; Pharmaceutical products development; Pharmaceutical research and development; Pharmaceutical research services; Platform as a service (PAAS) featuring computer software platforms for use in managing data and information in the field of medical clinical trials and research, for use in clinical trial monitoring and events capture in the nature of gathering and organizing information and data generated in medical clinical trials and research, and for use in clinical data capture, management and reporting in the nature of the results of medical clinical trials and research; Providing information on clinical studies via an interactive website; Providing medical and scientific research information in the field of clinical trials; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Providing medical and scientific research information in the fields of pharmaceuticals and genetics; Research and development in the pharmaceutical and biotechnology fields; Research on the subject of pharmaceuticals; Scientific research and development; Technical consulting in the field of pharmaceutical studies; Technical research in the field of pharmaceutical studies; Testing of pharmaceuticals |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, June 24, 2021 |
| Primary Code | 042 |
| First Use Anywhere Date | Wednesday, December 14, 2022 |
| First Use In Commerce Date | Wednesday, December 14, 2022 |
| Party Name | STELLAR IDEA LABS, INC. |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 03 - Corporation |
| Address | ROCKVILLE, MD 20850 |
| Party Name | STELLAR IDEA LABS, INC. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | ROCKVILLE, MD 20850 |
| Party Name | STELLAR IDEA LABS, INC. |
| Party Type | 11 - New Owner Before Publication |
| Legal Entity Type | 03 - Corporation |
| Address | ROCKVILLE, MD 20850 |
| Party Name | greatEvents, LLC |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | Rockville, MD 20850 |
| Event Date | Event Description |
| Tuesday, June 13, 2023 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| Tuesday, June 13, 2023 | REGISTERED-PRINCIPAL REGISTER |
| Friday, May 12, 2023 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
| Thursday, May 11, 2023 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
| Wednesday, May 10, 2023 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Tuesday, May 9, 2023 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Tuesday, May 9, 2023 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Friday, February 10, 2023 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Friday, February 10, 2023 | NON-FINAL ACTION E-MAILED |
| Friday, February 10, 2023 | SU - NON-FINAL ACTION - WRITTEN |
| Wednesday, January 18, 2023 | STATEMENT OF USE PROCESSING COMPLETE |
| Wednesday, December 14, 2022 | USE AMENDMENT FILED |
| Wednesday, January 18, 2023 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| Wednesday, December 14, 2022 | TEAS STATEMENT OF USE RECEIVED |
| Tuesday, June 14, 2022 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Tuesday, April 19, 2022 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, April 19, 2022 | PUBLISHED FOR OPPOSITION |
| Wednesday, March 30, 2022 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Thursday, March 17, 2022 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Tuesday, March 15, 2022 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Tuesday, March 15, 2022 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Tuesday, March 15, 2022 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Monday, November 15, 2021 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Monday, November 15, 2021 | NON-FINAL ACTION E-MAILED |
| Monday, November 15, 2021 | NON-FINAL ACTION WRITTEN |
| Friday, September 10, 2021 | ASSIGNED TO EXAMINER |
| Friday, June 25, 2021 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| Thursday, June 24, 2021 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Wednesday, April 7, 2021 | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP |
| Thursday, March 25, 2021 | NEW APPLICATION ENTERED |